Article

Expression of galectin-9 by IFN-γ stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways.

Department of Physiology, Kangwon National University School of Medicine, Chuncheon 200-701, Republic of Korea.
Biochemical and Biophysical Research Communications (impact factor: 2.48). 06/2011; 411(2):259-64. DOI:10.1016/j.bbrc.2011.06.110 pp.259-64
Source: PubMed

ABSTRACT Galectin-9 exhibited potent and selective eosinophil chemoattractant activity and attracted eosinophils in vitro and in vivo. Nasal polyposis is a chronic inflammatory disease of the upper airway characterized by the marked presence of inflammatory cells, particularly eosinophils. Thus, galectin-9 may be implicated in the pathogenesis of nasal polyposis. The study was designed to investigate whether interferon-gamma (IFN-γ) can induce the augmentation of galectin-9 expression and induce the expression of galectin-9 in nasal polyps. We examined the correlation between galectin-9 expression and eosinophil infiltration in nasal polyps. In addition, we identified the signaling pathways involved in the elevation of galectin-9 expression in response to IFN-γ. Our data demonstrate that the involvement of mitogen-activated protein kinases (MAPKs), phosphatidylinositol 3 phosphate kinase (PI3K), and Janus kinase/signal transducer and activator of transcription (JAK/STAT) may play important roles in the selective recruitment of eosinophils in nasal polyp tissues through the production of galectin-9. These findings suggest that galectin-9 expression is associated with eosinophil infiltration in polyps of patients with nasal polyposis.

0 0
 · 
0 Bookmarks
 · 
40 Views

Keywords

augmentation
 
chronic inflammatory disease
 
eosinophil infiltration
 
galectin-9
 
Galectin-9 exhibited potent
 
galectin-9 expression
 
IFN-γ
 
inflammatory cells
 
Janus kinase/signal transducer
 
marked presence
 
mitogen-activated protein kinases
 
nasal polyp tissues
 
nasal polyposis
 
nasal polyps
 
phosphatidylinositol 3 phosphate kinase
 
PI3K
 
selective recruitment
 
upper airway
 
vitro
 
vivo